Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production

As a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the infusion bottles, the company said in a statement.

New Delhi: Speciality pharma firm Eurolife Healthcare on Wednesday said it plans to invest over Rs 100 crore for expanding its infusion bottle capacity.

As a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the infusion bottles, the company said in a statement.

"Our investment planned over a period of a year together with the acquisition of high-speed machines to boost manufacturing will lend us huge international competitiveness and help us strengthen our market standings further," Eurolife Healthcare Pvt Ltd CEO Sandeep Toshniwal said.

Read Also: Eurolife Healthcare acquires Baxter Indias Form Fill Seal Infusion business

To be commissioned by the first quarter of 2020, the production capacity of these machines will add another 40 million bottles monthly, he added.

Started in 2001, the Mumbai-based Eurolife Healthcare manufactures and distributes a portfolio of healthcare formulations, intravenous infusions, ophthalmics, sterilized water for injections, nebules, tablets, capsules, ointment and creams.